GTS Securities’s DexCom DXCM Stock Holding History

GTS Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-195,800	Closed	-$13.1M	–	2049
2024 Q3	$13.1M	Buy	195,800 +137,500	+236%	+$11.3M	0.03%	397
2024 Q2	$6.61M	Sell	58,300 -26,300	-31%	-$3.33M	0.01%	701
2024 Q1	$11.7M	Sell	84,600 -137,000	-62%	-$17.2M	0.02%	440
2023 Q4	$27.5M	Buy	221,600 +101,300	+84%	+$10.3M	0.05%	245
2023 Q3	$11.2M	Buy	+120,300	New	+$13.6M	0.02%	554

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GTS Securities's DXCM Position: Q1 2026 in Review

GTS Securities reduced its DexCom (DXCM) stake by 23% in Q1 2026, selling an estimated $90.3K and leaving 4,362 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #1156.

GTS Securities first reported a position in DXCM in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.63M in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

GTS Securities held 4,362 shares of DexCom worth $274K as of Q1 2026.
GTS Securities sold 1,296 DexCom shares in Q1 2026, an estimated $90.3K.
DexCom made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1156 holding.
GTS Securities first reported a position in DexCom in Q2 2023 and has held it in 10 quarters since.
GTS Securities's DexCom position peaked at $2.63M in Q3 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.